# | Title | Journal | Year | Citations |
---|
1 | Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy | Clinical Laboratory | 2002 | 216 |
2 | Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption | Clinical Laboratory | 2006 | 173 |
3 | Performance of a matrix-assisted laser desorption ionization-time-of-flight mass spectrometry system for the identification of bacterial isolates in the clinical routine laboratory | Clinical Laboratory | 2009 | 145 |
4 | Haptoglobin: function and polymorphism | Clinical Laboratory | 2000 | 144 |
5 | Reference range and method comparison studies for enzymatic and Jaffé creatinine assays in plasma and serum and early morning urine | Clinical Laboratory | 2000 | 131 |
6 | Laboratory-based diagnosis of brucellosis--a review of the literature. Part II: serological tests for brucellosis | Clinical Laboratory | 2003 | 128 |
7 | Mutations in the transketolase-like gene TKTL1: clinical implications for neurodegenerative diseases, diabetes and cancer | Clinical Laboratory | 2005 | 126 |
8 | Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance | Clinical Laboratory | 2003 | 125 |
9 | Neutrophil- and Platelet-to-Lymphocyte Ratios are Correlated with Disease Activity in Rheumatoid Arthritis | Clinical Laboratory | 2015 | 113 |
10 | Human Serum Albumin and Its Relation with Oxidative Stress | Clinical Laboratory | 2013 | 102 |
11 | Lipid and lipoprotein profile in physiological pregnancy | Clinical Laboratory | 2007 | 100 |
12 | MicroRNAs in health and disease--basic science and clinical applications | Clinical Laboratory | 2012 | 99 |
13 | Laboratory-based diagnosis of brucellosis--a review of the literature. Part I: Techniques for direct detection and identification of Brucella spp | Clinical Laboratory | 2003 | 89 |
14 | Reference intervals for testosterone, androstenedione and SHBG levels in healthy females and males from birth until old age | Clinical Laboratory | 2005 | 88 |
15 | Relationship of oxidative stress with obesity and its role in obesity induced metabolic syndrome | Clinical Laboratory | 2012 | 86 |
16 | Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome | Clinical Laboratory | 2005 | 85 |
17 | Phlebotomy issues and quality improvement in results of laboratory testing | Clinical Laboratory | 2006 | 77 |
18 | Molecular biology of partial D and weak D: implications for blood bank practice | Clinical Laboratory | 2002 | 75 |
19 | Elevated HSP27, HSP70 and HSP90 alpha in chronic obstructive pulmonary disease: markers for immune activation and tissue destruction | Clinical Laboratory | 2009 | 74 |
20 | Inhibitors of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura | Clinical Laboratory | 2001 | 73 |
21 | Evaluation of sensitivity for wild type and mutant forms of hepatitis B surface antigen by four commercial HBsAg assays | Clinical Laboratory | 2004 | 67 |
22 | Umbilical Cord Mesenchymal Stem Cell Transfusion Ameliorated Hyperglycemia in Patients with Type 2 Diabetes Mellitus | Clinical Laboratory | 2014 | 65 |
23 | Oxidative stress and role of antioxidant supplementation in critical illness | Clinical Laboratory | 2007 | 65 |
24 | Free thyroxine measured with equilibrium dialysis and nine immunoassays decreases in late pregnancy | Clinical Laboratory | 2004 | 64 |
25 | Expression of Serum miR-16, let-7f, and miR-21 in Patients with Hepatocellular Carcinoma and their Clinical Significances | Clinical Laboratory | 2014 | 62 |
26 | B-type natriuretic peptide (BNP)--validation of an immediate response assay | Clinical Laboratory | 2001 | 61 |
27 | Circulating endothelial cells: markers of vascular dysfunction | Clinical Laboratory | 2005 | 61 |
28 | Determination of cortisol in saliva and serum by a luminescence-enhanced enzyme immunoassay | Clinical Laboratory | 2004 | 60 |
29 | Reduced expression of chemerin is associated with a poor prognosis and a lowed infiltration of both dendritic cells and natural killer cells in human hepatocellular carcinoma | Clinical Laboratory | 2011 | 60 |
30 | CD4+CD25(hi) regulatory T cells in healthy males and females mediate gender difference in the prevalence of autoimmune diseases | Clinical Laboratory | 2012 | 60 |
31 | Simple, rapid and sensitive determination of epinephrine and norepinephrine in urine and plasma by non-competitive enzyme immunoassay, compared with HPLC method | Clinical Laboratory | 2002 | 59 |
32 | Early urinary and plasma biomarkers for experimental diabetic nephropathy | Clinical Laboratory | 2012 | 59 |
33 | Cryoprotectant-free vitrification of human spermatozoa in large (up to 0.5 mL) volume: a novel technology | Clinical Laboratory | 2011 | 58 |
34 | Human serum albumin and its relation with oxidative stress | Clinical Laboratory | 2013 | 57 |
35 | Detection of procalcitonin (PCT) in healthy controls and patients with local infection by a sensitive ILMA | Clinical Laboratory | 2002 | 55 |
36 | 25-Hydroxy-Vitamin D Status: Limitations in Comparison and Clinical Interpretation of Serum-Levels Across Different Assay Methods | Clinical Laboratory | 2014 | 53 |
37 | Measurement of vitamin D status: background, clinical use, and methodologies | Clinical Laboratory | 2006 | 53 |
38 | Normal Reference Intervals of Neutrophil-To-Lymphocyte Ratio, Platelet-To-Lymphocyte Ratio, Lymphocyte-To-Monocyte Ratio, and Systemic Immune Inflammation Index in Healthy Adults: a Large Multi-Center Study from Western China | Clinical Laboratory | 2019 | 52 |
39 | Hyperhomocysteinemia: a new risk factor for degenerative diseases | Clinical Laboratory | 2002 | 51 |
40 | The fibrinolytic system in newborns and children | Clinical Laboratory | 2006 | 51 |
41 | Hepatitis B--an important public health issue | Clinical Laboratory | 2001 | 49 |
42 | Hepatitis B surface antigen escape mutant in a first time blood donor potentially missed by a routine screening assay | Clinical Laboratory | 2004 | 49 |
43 | Biological background and role of adiponectin as marker for insulin resistance and cardiovascular risk | Clinical Laboratory | 2005 | 49 |
44 | Intestinal Fatty Acid Binding Protein (I-FABP) as a Promising Test for Crohn's Disease: A Preliminary Study | Clinical Laboratory | 2015 | 48 |
45 | Results from a multicenter evaluation of the 4th generation Elecsys Troponin T assay | Clinical Laboratory | 2007 | 48 |
46 | Plasma Levels of CXCL1 (GRO-α) and CXCL10 (IP-10) are Elevated in Type 2 Diabetic Patients: Evidence for the Involvement of Inflammation and Angiogenesis / Angiostasis in this Disease State | Clinical Laboratory | 2013 | 47 |
47 | Improved Glycemic Control in Patients with Advanced Type 2 Diabetes Mellitus Taking Urtica dioica Leaf Extract: A Randomized Double-Blind Placebo-Controlled Clinical Trial | Clinical Laboratory | 2013 | 47 |
48 | Mean Platelet Volume (MPV) may Simply Predict the Severity of Sepsis in Preterm Infants | Clinical Laboratory | 2014 | 47 |
49 | Clinical Value of Combined Detection of CK-MB, MYO, cTnI and Plasma NT-proBNP in Diagnosis of Acute Myocardial Infarction | Clinical Laboratory | 2017 | 47 |
50 | Comprehensive Analysis of lncRNA and mRNA Expression Profiles in Lung Cancer | Clinical Laboratory | 2017 | 47 |